Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Intravitreal Ganciclovir for CMV Retinitis in HIV-negative Patients
NCT03598452Completed
- Sponsor
- Aier Eye Hospital
- Start
- Jan 2014
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Open-label, single-arm trial of ganciclovir in cytomegalovirus retinitis, sponsored by Aier Eye Hospital. Primary endpoint: CMV-DNA load in aqueous humor. Started Jan 2014; status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT03598452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598452.